Dion Gisele 4
4 · Inhibikase Therapeutics, Inc. · Filed Jul 5, 2023
Insider Transaction Report
Form 4
Dion Gisele
Director
Transactions
- Award
Stock Option (right to buy)
2023-06-30+6,667→ 6,667 totalExercise: $3.61Exp: 2030-06-30→ Common Stock (6,667 underlying)
Footnotes (1)
- [F1]The options will vest on the earlier of June 30, 2024 or the day prior to the next annual meeting of stockholders, subject to the director's continued service through such date.